Deoxyschizandrin-containing drug composition and application thereof
A technology of schisandrin A and composition, which is applied in the direction of drug combination, ether/acetal active ingredients, blood diseases, etc., to achieve the effect of preventing platelet aggregation and preventing thrombosis
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0016] Example 1 Determining the Effect of Schizandrin A on Platelet Aggregation
[0017] The platelet aggregation rate was measured with a platelet aggregation coagulation factor analyzer (LG-PABER-I, Beijing Shidi Scientific Instrument Company). The instrument adopts photoelectric turbidimetry to test platelet aggregation: platelet poor plasma (PPP) is used as the substrate, and platelet rich plasma (PRP) is used for measurement. Under the stirring of the magnetic beads, the inducer is added to the PRP, the platelets aggregate, and the transmittance of the PRP increases or the turbidity decreases. The change of light and turbidity is converted into the change of electrical signal, so as to calculate the aggregation rate of platelets.
[0018] Aggregation rate=(measured voltage value-PPP photoelectric voltage value) / (PRP photoelectric voltage value-PPP photoelectric voltage value)*100%.
[0019] 1. Determination of the effect of different concentrations (0.001, 0.01, 0.1, 1...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com